BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
  • Homepage
  • Online Submission
Number of total visits
30949534
Number of visits today
6343
Number of downloads
13478724
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Liu Y, Zhou Y, Xu J, Luo H, Zhu Y, Zeng X, Dong F, Wei Z, Yan F, Zheng H. Ultrasound molecular imaging-guided tumor gene therapy through dual-targeted cationic microbubbles. Biomater Sci 2021;9:2454-66. [PMID: 33594996 DOI: 10.1039/d0bm01857k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Schwartz MR, Debski AC, Price RJ. Ultrasound-targeted nucleic acid delivery for solid tumor therapy. J Control Release 2021;339:531-46. [PMID: 34655678 DOI: 10.1016/j.jconrel.2021.10.010] [Reference Citation Analysis]
2 Yuan C, Li Y, Liu L, Tayier B, Yang L, Guan L, Mu Y. Experimental Study on the Compatibility and Characteristics of a Dual-Target Microbubble Loaded with Anti-miR-33. Int J Nanomedicine 2021;16:6265-80. [PMID: 34539179 DOI: 10.2147/IJN.S324514] [Reference Citation Analysis]
3 Omidi Y, Mobasher M, Castejon A, Mahmoudi M. Recent advances in nanoscale targeted therapy of HER2-positive breast cancer. J Drug Target 2022;:1-48. [PMID: 35321601 DOI: 10.1080/1061186X.2022.2055045] [Reference Citation Analysis]
4 Liu F, Mao Y, Yan J, Sun Y, Xie Z, Li F, Yan F, Zhang H, Zhang P. Bionic Microbubble Neutrophil Composite for Inflammation-Responsive Atherosclerotic Vulnerable Plaque Pluripotent Intervention. Research 2022;2022:1-11. [DOI: 10.34133/2022/9830627] [Reference Citation Analysis]
5 Endo-takahashi Y, Negishi Y. Gene and oligonucleotide delivery via micro- and nanobubbles by ultrasound exposure. Drug Metabolism and Pharmacokinetics 2022. [DOI: 10.1016/j.dmpk.2022.100445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345